QDEL:NASDAQ
Quidelortho Corp
$10.74
arrow_upward
+1.13%(+0.12) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$10.68
High
$11.19
Low
$10.28
Mkt. cap
736.90M
Avg. vol.
2.46M
Volume
2.04M
52-wk high
$35.58
52-wk low
$9.92
EPS
-$5.41
Beta
0.77
Shares outstanding
68.61M
No. of employees
6K
Open
$10.68
High
$11.19
Low
$10.28
Mkt. cap
736.90M
Avg. vol.
2.46M
Volume
2.04M
52-wk high
$35.58
52-wk low
$9.92
EPS
-$5.41
Beta
0.77
Shares outstanding
68.61M
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance
·
54 minutes ago
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Howl.Link
·
7 hours ago
Weekly Market Outlook – Not A Decisive Reversal Effort - TalkMarkets
صحيفة مال
·
13 hours ago
Nasdaq Records Best Weekly Performance Since August
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorHealth Care
IndustryMedical device
Websitequidelortho.com